Cargando…
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19’s m...
Autores principales: | Sørensen, Birger, Susrud, Andres, Dalgleish, Angus George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468800/ https://www.ncbi.nlm.nih.gov/pubmed/34192262 http://dx.doi.org/10.1017/qrd.2020.8 |
Ejemplares similares
-
Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
por: Piadel, Katarzyna, et al.
Publicado: (2022) -
Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022) -
Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020) -
SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
por: Kakulavarapu, Srividya, et al.
Publicado: (2021) -
Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
por: Sadat, Seyed Mehdi, et al.
Publicado: (2021)